IBRN Performance — iShares Neuroscience and Healthcare ETF
Data updated: 2026-10-13
IBRN returned +13.18% year to date and +58.36% over one year to Jul 2026. The annualised 3-year return is +14.62%. The fund beat its Global Health Care Equity category average: $100 invested three years ago grew to $151, against $127 for the category, and to $158 over one year, against $123. Volatility over the past three years was 23.43% a year. In the 12 months to Jul 2026 the fund took in a net $0, and assets reached $5.49M.
IBRN Growth of $100
What $100 invested in iShares Neuroscience and Healthcare ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Health Care Equity category average over the same months.
| Period | IBRN | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $158 | $123 |
| 3 years (Aug 2023 – Jul 2026) | $151 | $127 |
| Since data start (Aug 2022 – Jul 2026) | $147 | $127 |
IBRN Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.18% |
| 1 year | +58.36% |
| 3 years (annualised) | +14.62% |
IBRN Annual Returns
Calendar-year total returns of iShares Neuroscience and Healthcare ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +13.18% |
| 2025 | +28.28% |
| 2024 | −2.68% |
| 2023 | +0.99% |
| 2022 (Aug–Dec) | +2.96% |
IBRN Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.9% | −1.4% | +2.4% | +4.8% | +4.0% | +8.5% | −6.0% | — | — | — | — | — |
| 2025 | +2.1% | −4.1% | −10.2% | +1.4% | −3.2% | −0.2% | +6.5% | +7.1% | +7.4% | +12.4% | +5.3% | +2.8% |
| 2024 | −2.8% | +0.8% | −0.5% | −8.1% | +0.3% | −0.2% | +9.2% | +0.8% | −3.3% | +6.6% | +1.5% | −5.8% |
| 2023 | +3.4% | −6.8% | −5.0% | +3.9% | −2.1% | +0.3% | +1.5% | −6.5% | −8.9% | −7.7% | +11.1% | +22.0% |
| 2022 | — | — | — | — | — | — | — | −4.5% | +2.7% | +1.8% | +5.7% | −2.4% |
IBRN Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 23.43%
- 3-year Sharpe ratio: 0.43 (vs 4.5% risk-free rate)
- Best month: +22.00% (Dec 2023)
- Worst month: −10.24% (Mar 2025)
IBRN Fund Flows
Monthly money in and out of iShares Neuroscience and Healthcare ETF, from SEC Form N-PORT.
- 12-month net flow: $0
- 12-month gross sales (incl. reinvestments): $0
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $0 | $0 |
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
IBRN Assets Under Management
Net assets of iShares Neuroscience and Healthcare ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $5.49M |
| 2026-04-30 | $5.17M |
| 2026-01-31 | $4.89M |
| 2025-10-31 | $4.52M |
| 2025-07-31 | $3.50M |
| 2025-04-30 | $3.40M |
| 2025-01-31 | $3.89M |
| 2024-10-31 | $4.01M |
| 2024-07-31 | $3.86M |
| 2024-04-30 | $3.53M |
| 2024-01-31 | $3.83M |
| 2023-10-31 | $3.87M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.